Lisa G. Roth, M.D.

Pediatric Hematology-Oncology
Lisa Roth

 

Dr. Lisa Roth is an Assistant Professor in the Departments of Pediatrics at Weill Cornell Medical College.  She is also an Assistant Attending Pediatrician at New York-Presbyterian Phyllis and David Komansky Center for Children's Health.   Dr. Roth has been named the Charles, Lillian, and Betty Neuwirth Clinical Scholar in Pediatric Oncology.
  
Dr. Roth completed her undergraduate work at Duke University.  She received her medical degree from New York University School of Medicine.  Dr. Roth conducted her residency at NewYork-Presbyterian/Weill Cornell and her fellowship in pediatric hematology/oncology at Memorial Sloan-Kettering Cancer Center and NewYork-Presbyterian where she served as chief fellow.
   
Dr. Roth specializes in treating children, adolescents and young adults with lymphoma.  She is a member of the Children’s Oncology Group and an active participant in Hodgkin lymphoma and non-Hodgkin lymphoma clinical trials.  She is also a member of the Weill Cornell Center for Lymphoma, a group which is internationally recognized for it’s leadership in the treatment of patients with lymphoma.
    
Dr. Roth’s research focuses on identifying new treatments for children with lymphoma.  She is particularly interested identifying novel targeted therapies.  Targeted therapies may be less toxic than conventional chemotherapy and may be able to rescue those patients with chemotherapy-resistant disease.  Dr. Roth has been recognized for her work with awards from the National Institutes of Health (NIH), the Rally Foundation for Childhood Cancer, the Sass Foundation for Medical Research, and the Lymphoma Research Foundation.

Publications

  1. Giulino-Roth L, Ricafort R, Kernan NA, Small TN, Trippett TM, Steinherz PG, Prockop SE, Scaradavou A, Chiu M, O’Reilly RJ, Boulad F.  Ten-year follow up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.  Pediatric Blood and Cancer, 2013 Dec;60(12):2018-24.

  2. Barth MJ, Goldman S, Smith L, Perkins S, Shiramizu B, Gross TG, Harrison L, Sanger W, Geyer MB, Giulino-Roth L, Cairo MC.  Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: A Children’s Oncology Group (COG) report.  British Journal of Haematology, in press.
  3. Giulino-Roth L, Wang K, MacDonald TY, Mathew S, Tam Y, Cronin M, Palmer G, Lucena-Silva N, Pedrosa F, Pedrosa M, Teruya-Feldstein J, Chagat G, Alobeid B, Leoncini L, Bellan C, Rogena E, Pinkey KA, Rubin M, Ribeiro RC, Yelensky R, Tam W, Stephens PJ, Cesarman E. Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in anti-apoptotic and chromatin-remodeling genes.  Blood. 2012 Dec 20; 120(26):5181-4.
  4. Giulino L, Giunan EC, Gillio AP, Drachtman J, Teruya-Feldstein J, Boulad F. Sweet Syndrome in Patients with Fanconi Anemia: Association with Extracutaneous Manifestations and Progression of Hematologic Disease. British Journal of Haematology. 2011 Jul;154(2):278-81. PMID 21501135.
  5. Giulino L, Mathew S, Ballon G, Chadburn A, Barouk S, Antonicelli G, Leoncini L, Liu YF, Gogineni S, Tam W, Cesarman E. A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma. Blood. 2011 May 5;117(18):4852-4. PMID: 21406721.
  6. Bussel J, Giulino L, Lee S, Sandborg C, Patel VL and Stiehm ER. Update on Therapeutic Monoclonal Antibodies. Current Problems In Pediatric And Adolescent Health Care. 37 (4);113-129, 2007. PMID: 17434008
  7. Giulino L, Bussel J, Neufeld E, and the Pediatric and Platelet Immunology Committees of the TMH clinical trial network. Treatment with Rituximab in Benign and Malignant Hematologic Disorders in Children. Journal of Pediatrics, April 2007. PMID: 17382107
  8. Giulino L, Gammon P, Sullivan K, Franklin M, Foa E, Maid R, March JS. Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection? Journal of Child & Adolescent Psychopharmacology. 12(2):157-64, 2002. PMID:12188984
  9. Giulino L, Gammon P, Sullivan K, Franklin M, Foa E, Maid R, March JS. Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection?  Journal of Child & Adolescent Psychopharmacology. 2002; 12(2):157-64.

Honors and Awards

  1. 2013   Charles, Lillian and Betty Neuwirth Clinical Scholar Award in Pediatric Oncology
  2. 2012   Lymphoma Research Foundation, Postdoctoral Fellowship Award
  3. 2012 Sass Foundation for Medical Research, Transition Award
  4. 2012 NIH Loan Repayment Award, National Cancer Institute
  5. 2010 Chief Fellow, Pediatric Hematology/Oncology, Memorial Sloan-Kettering Cancer Center and New York Presbyterian – Weill Cornell
  6. 2011 Rally Foundation for Childhood Cancer Research Award
  7. 2005 American Medical Women's Association Glasgow-Rubin Achievement Award
  8. 2005 Alpha Omega Alpha, New York University School of Medicine
  9. 2004 Milton B Rosenbluth Research Travel Grant
  10. 2001 Cum Laude, Duke University